Nuo Therapeutics, Inc.
AURX
$1.23
$0.043.36%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 152.64% | 168.81% | 177.74% | 178.19% | 91.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 152.64% | 168.81% | 177.74% | 178.19% | 91.94% |
| Cost of Revenue | 275.78% | 273.88% | 372.80% | 304.68% | 144.10% |
| Gross Profit | 116.31% | 133.82% | 123.14% | 131.29% | 80.66% |
| SG&A Expenses | 12.05% | 16.93% | 35.19% | 37.47% | 41.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.14% | 42.22% | 63.68% | 65.79% | 49.12% |
| Operating Income | 74.45% | 40.08% | 7.93% | 6.46% | -20.30% |
| Income Before Tax | 57.27% | 17.10% | -16.47% | 6.97% | -20.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 57.27% | 17.10% | -16.47% | 6.97% | -20.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.27% | 17.10% | -16.47% | 6.97% | -20.29% |
| EBIT | 74.45% | 40.08% | 7.93% | 6.46% | -20.30% |
| EBITDA | 77.68% | 41.87% | 10.09% | 9.84% | -16.87% |
| EPS Basic | 58.99% | 19.50% | -14.29% | 11.02% | -14.88% |
| Normalized Basic EPS | 58.62% | 20.00% | 10.71% | 10.13% | -14.47% |
| EPS Diluted | 58.99% | 19.50% | -14.29% | 11.02% | -14.88% |
| Normalized Diluted EPS | 58.62% | 20.00% | 10.71% | 10.13% | -14.47% |
| Average Basic Shares Outstanding | 3.38% | 3.14% | 1.88% | 4.22% | 4.85% |
| Average Diluted Shares Outstanding | 3.38% | 3.14% | 1.88% | 4.22% | 4.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |